| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/05/2007 | US20070154401 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154400 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 07/05/2007 | US20070154399 Immunotherapy for immune suppressed patients |
| 07/05/2007 | US20070154392 treating a cancerous disease which includes characterizing a disease by an overexpression of one or more somatostatin receptors, exposing such somatostatin receptors to a pharmaceutical formulation containing a somatostatin analogue which binds to the one or more somatostatin receptor |
| 07/05/2007 | US20070154391 Monoclonal antibodies; hybridomas; competitive binding |
| 07/05/2007 | DE102005063062A1 Cosmetic or dermatological composition for topical treatment of the skin comprises two soya protein hydrolyzates and a wheat protein hydrolyzate |
| 07/05/2007 | DE102005062440A1 Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen Protein-based carrier system to overcome resistance of tumor cells |
| 07/05/2007 | DE102005054909A1 Method for inhibiting cell growth such as tumor, cancer or HIV cells, comprises applying nucleophosmin/B23-binding peptide, for up-regulating p53 transcriptional activity |
| 07/05/2007 | DE102005054700A1 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases |
| 07/05/2007 | CA2641828A1 Isolated mcpip and methods of use |
| 07/05/2007 | CA2635770A1 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 07/05/2007 | CA2635726A1 Methods and compositions related to mutant kunitz domain i of tfpi-2 |
| 07/05/2007 | CA2635456A1 Histidine-containing diastereomeric peptides and uses thereof |
| 07/05/2007 | CA2635375A1 Synergistic effect between a cyanogenic system and another oxidative inducer for the treatment of tumours |
| 07/05/2007 | CA2635342A1 Cytoprotective pharmaceutical combination which can be used in the prevention and treatment of systemic inflammatory response syndrome |
| 07/05/2007 | CA2635013A1 Use of a topical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 07/05/2007 | CA2634934A1 Endometriosis cell targeting peptide and uses thereof |
| 07/05/2007 | CA2634840A1 Novel t-helper antigenic determinant (thd) peptides |
| 07/05/2007 | CA2634760A1 Compositions and methods for producing a composition |
| 07/05/2007 | CA2634547A1 Stable ctla4 formulation for subcutaneous administration |
| 07/05/2007 | CA2634067A1 Carbohydrate-mimetic peptides and use thereof in pharmaceutical formulations |
| 07/05/2007 | CA2634053A1 Compositions comprising polycation-complexed protein crystals and methods of treatment using them |
| 07/05/2007 | CA2634045A1 Protease compositions for the treatment of damaged tissue |
| 07/05/2007 | CA2634016A1 Compositions and methods for treating obesity and related metabolic disorders |
| 07/05/2007 | CA2633238A1 Compositions and methods for oxalate reduction |
| 07/05/2007 | CA2633066A1 Enzymes for reduced immunological stress |
| 07/05/2007 | CA2631948A1 Improved thyroid-stimulating hormone receptor polypeptide agonist glycoforms to treat metabolic syndrome |
| 07/05/2007 | CA2631645A1 Use of parathyroid hormone for treating periodontal and for other dental applications |
| 07/04/2007 | EP1804064A1 Diagnostics and therapeutics for macular degeneration |
| 07/04/2007 | EP1804061A1 Use of the 5E2 protein for in vitro diagnosis of infections in Legionella pneumophila |
| 07/04/2007 | EP1803810A1 Integrin antagonists |
| 07/04/2007 | EP1803808A1 Lecithinized superoxide dismutase composition and process for producing the same |
| 07/04/2007 | EP1803807A2 Virulence genes, proteins, and their use |
| 07/04/2007 | EP1803733A2 Method for treating inflammation |
| 07/04/2007 | EP1803732A2 Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions |
| 07/04/2007 | EP1803730A1 Albumin fusion proteins |
| 07/04/2007 | EP1803706A1 HIV protease inhibitors based on amino acid derivatives |
| 07/04/2007 | EP1803465A1 Pharmaceutical composition and method of treating hepatitis with arginases |
| 07/04/2007 | EP1803464A1 External preparation for treating skin ulcer |
| 07/04/2007 | EP1803454A1 Treatment of cancer by a combination of non-ionizing radiation and androgen deprivation |
| 07/04/2007 | EP1803445A2 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/04/2007 | EP1803417A1 Dry hemostatic compositions and methods for their preparation |
| 07/04/2007 | EP1802764A2 Biomarkers for breast cancer |
| 07/04/2007 | EP1802656A1 Tweak receptor |
| 07/04/2007 | EP1802653A2 Mam domain containing protein |
| 07/04/2007 | EP1802649A1 Solid phase peptide sythesis |
| 07/04/2007 | EP1802645A2 Recombinant bifunctional protein of human lutropin receptor and human chorionic gonadotropin b-subunit and uses thereof |
| 07/04/2007 | EP1802349A1 Pharmaceutical compositions comprising a toxin-binding oligosaccharide and a polymeric particle |
| 07/04/2007 | EP1802346A1 Sustained release pharmaceutical composition |
| 07/04/2007 | EP1802331A2 Treatment of glomerular basement membrane disease involving matrix metalloproteinase-12 |
| 07/04/2007 | EP1802329A1 A pharmaceutical formulation comprising crystalline insulin and dissolved insulin |
| 07/04/2007 | EP1802328A1 Use of organic compounds |
| 07/04/2007 | EP1802327A1 Combination anti-viral compositions comprising castanospermine and methods of use |
| 07/04/2007 | EP1802326A2 Methods for treating bone tumors using bone morphogenic proteins |
| 07/04/2007 | EP1802325A2 Crig polypeptide for prevention and treatment of complement-associated disorders |
| 07/04/2007 | EP1802324A1 Intestinal epithelial glucose sensor |
| 07/04/2007 | EP1802323A2 Plant pr-5 proteins as mammalian therapeutic agents |
| 07/04/2007 | EP1802322A2 Prion protein binding materials and methods of use |
| 07/04/2007 | EP1802321A2 Compositions and methods for modulating pgc-1-alpha to treat neurological diseases and disorders |
| 07/04/2007 | EP1802270A1 Dermatological and/or cosmetic composition containing polypeptides |
| 07/04/2007 | EP1478741A4 Combination of a growth factor and a protease enzyme |
| 07/04/2007 | EP1470141A4 Glycosulfopeptide inhibitors and methods of use thereof |
| 07/04/2007 | EP1423143A4 Crystal forms and mutants of rank ligand |
| 07/04/2007 | EP1412380B1 Broad spectrum antibiotic peptides of the phylloseptin family |
| 07/04/2007 | EP1339349A4 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 07/04/2007 | EP1311699B1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 07/04/2007 | EP1286690B1 Use of alpha-msh and epo for the manufacture of a medicament for preventing or treating ischemic conditions |
| 07/04/2007 | EP1242823B1 Selecting library members capable of binding to epitopes |
| 07/04/2007 | EP1194560B1 Antigenic neisserial peptides |
| 07/04/2007 | EP1161449B1 Modulators of beta-amyloid peptide aggregation comprising d-amino acids |
| 07/04/2007 | EP1159427B1 Gp120 mutants and biological applications |
| 07/04/2007 | EP1121382B9 Interferon-beta fusion proteins and uses |
| 07/04/2007 | EP1082011B1 Avian polyomavirus vaccines in psittacine birds |
| 07/04/2007 | EP1079851B1 Use of anti-prolactin agents to treat cancer |
| 07/04/2007 | EP1054594B1 Inotropic and diuretic effects of exendin and glp-1 |
| 07/04/2007 | EP1053023B1 Systemic delivery of serum stable plasmid lipid particles for cancer therapy |
| 07/04/2007 | EP1034301B1 Inhibition of an fgf-binding protein using ribozymes |
| 07/04/2007 | EP0958834B1 Use of peptide-based immunotherapeutic agent |
| 07/04/2007 | EP0948542B1 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 07/04/2007 | EP0942750B1 Anti-class ii mhc binding agents for use in xenotransplantation |
| 07/04/2007 | EP0868435B1 High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein |
| 07/04/2007 | EP0567566B2 Methods for treating tumor necrosis factor mediated diseases |
| 07/04/2007 | CN1993469A Recombinant alpha-fetoprotein, method and means for preparation thereof, compositions on the base thereof and use thereof |
| 07/04/2007 | CN1993467A Gene related with prostate disease and encoding polypeptides and its application |
| 07/04/2007 | CN1993463A Follistatin mutant polypeptide |
| 07/04/2007 | CN1993139A Stabilized interferon liquid formulations |
| 07/04/2007 | CN1993138A Method of stabilizing proteins |
| 07/04/2007 | CN1993137A Compositions and methods for treatment of cardiovascular disease |
| 07/04/2007 | CN1993136A Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents |
| 07/04/2007 | CN1993116A Methods for improving bioavailability of a renin inhibitor |
| 07/04/2007 | CN1993110A Stable particle formulations of erythropoietin receptor agonists |
| 07/04/2007 | CN1993108A Stable suspension formulations of erythropoietin receptor agonists |
| 07/04/2007 | CN1993048A Follistatin domain containing proteins |
| 07/04/2007 | CN1990875A Globin zymolyte and its preparation and application |
| 07/04/2007 | CN1990865A Method of treating endotoxemia |
| 07/04/2007 | CN1990862A Production method of recombined human alpha1-thymus peptide and preparation thereof |
| 07/04/2007 | CN1990504A Earthworm protein suppressing cancer cell accretion by road spectrum |
| 07/04/2007 | CN1990043A Use of recombinant human granulocyte macrophagocyte colony stimulating factor in preparation of drug for preventing and treating hepatitis B |
| 07/04/2007 | CN1990039A Modification method of polymeric hemoglobin |
| 07/04/2007 | CN1990038A Method for preparing narrow distribution low-molecular-weight polymeric hemoglobin on gel blocking chromatographic column |